ATE356872T1 - Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika - Google Patents

Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika

Info

Publication number
ATE356872T1
ATE356872T1 AT03740540T AT03740540T ATE356872T1 AT E356872 T1 ATE356872 T1 AT E356872T1 AT 03740540 T AT03740540 T AT 03740540T AT 03740540 T AT03740540 T AT 03740540T AT E356872 T1 ATE356872 T1 AT E356872T1
Authority
AT
Austria
Prior art keywords
proteins
maba
fabg1
protein
antibiotics
Prior art date
Application number
AT03740540T
Other languages
English (en)
Inventor
Annaik Quemard
Gilles Labesse
Mamadou Daffe
Hedia Marrakchi
Dominique Douguet
Martin Cohen-Gonsaud
Stephanie Ducasse
Original Assignee
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Univ Montpellier I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Inst Nat Sante Rech Med, Univ Montpellier I filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE356872T1 publication Critical patent/ATE356872T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT03740540T 2002-03-29 2003-03-28 Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika ATE356872T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204018A FR2837836B1 (fr) 2002-03-29 2002-03-29 UTILISATION DE LA PROTEINE Maba (FABG1) DE MYCOBACTERIUM TUBERCULOSIS POUR LA CONCEPTION ET LE CRIBLAGE D'ANTIBIOTIQUES

Publications (1)

Publication Number Publication Date
ATE356872T1 true ATE356872T1 (de) 2007-04-15

Family

ID=27839347

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740540T ATE356872T1 (de) 2002-03-29 2003-03-28 Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika

Country Status (8)

Country Link
US (2) US20060035294A1 (de)
EP (1) EP1490491B1 (de)
AT (1) ATE356872T1 (de)
AU (1) AU2003258723A1 (de)
DE (1) DE60312497T2 (de)
ES (1) ES2283790T3 (de)
FR (1) FR2837836B1 (de)
WO (1) WO2003082911A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113291A1 (en) * 2006-03-23 2010-05-06 Centre National De La Recherche Scientifique Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09501823A (ja) * 1993-05-13 1997-02-25 アール.,ジュニア ヤコブス,ウィリアム inhA遺伝子を用いるミコバクテリア感染の検出および処置のための方法および組成物
AU6949694A (en) * 1993-05-13 1994-12-12 Agresearch Limited Use of genes of m. tuberculosis, m. bovis and m. smegmatis which confer isoniazid resistance

Also Published As

Publication number Publication date
FR2837836B1 (fr) 2005-04-22
DE60312497D1 (de) 2007-04-26
EP1490491A2 (de) 2004-12-29
AU2003258723A1 (en) 2003-10-13
AU2003258723A8 (en) 2003-10-13
DE60312497T2 (de) 2007-09-20
US20100240084A1 (en) 2010-09-23
EP1490491B1 (de) 2007-03-14
ES2283790T3 (es) 2007-11-01
FR2837836A1 (fr) 2003-10-03
US20060035294A1 (en) 2006-02-16
WO2003082911A3 (fr) 2004-04-01
WO2003082911A2 (fr) 2003-10-09

Similar Documents

Publication Publication Date Title
ATE293696T1 (de) Mutierte alpha-amylase enzyme mit erhöhter stabilität
ATE478944T1 (de) Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
ATE398179T1 (de) Von rna polymerasen abstammende polypeptide und ihre verwendungen
EP1490677A4 (de) Computerberechnungsverfahren zur konstruktion von enzymen zum einbau von aminosäureanalogen in proteine
NZ602351A (en) Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
NO20013801D0 (no) Ny karbonyl reduktase, gen derav og metode for anvendelse av det samme
ATE462000T1 (de) Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin
ATE500266T1 (de) Methode zur verbesserung der wirksamkeit von biologischen antwort-verändernden proteinen und exemplarische muteine
WO2007036299A3 (de) Verfahren zur amidierung von polypeptiden mit c-terminalen basischen aminosäuren unter verwendung spezifischer endoproteasen
DE60313866D1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO2008146259A3 (en) Malt1 specific cleavage in assay and screening method
ATE356872T1 (de) Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika
DE69615185D1 (de) Faktor ix bindende peptide abgeleitet von faktor vii und ihre verwendung als inhibitoren der blutgerinnung
MY143274A (en) Recombinant production of heparin binding proteins
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
ATE481983T1 (de) Frpb proteinmutante und verfahren zur erneuten faltung
DE60121225D1 (de) Tetrapeptidische tryptase substrate und ihre verwendung zur tryptase aktivitätbestimmung
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE390481T1 (de) Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren
EP1462516A4 (de) Mutierte 6-phosphogluconat-dehydrogenase
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
WO2005077975A3 (en) Polypeptides comprising the pleckstrin homology domain of ect2 and their binding specificities to phosphatidylinositols
MY150639A (en) T cell adhesion molecule and antibody thereto

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties